1. Home
  2. SOBR vs RDHL Comparison

SOBR vs RDHL Comparison

Compare SOBR & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$0.57

Market Cap

3.3M

ML Signal

HOLD

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

N/A

Current Price

$0.80

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SOBR
RDHL
Founded
2004
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.8M
IPO Year
2008
2012

Fundamental Metrics

Financial Performance
Metric
SOBR
RDHL
Price
$0.57
$0.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
174.4K
22.5K
Earning Date
04-10-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
103.55
N/A
EPS
6.12
N/A
Revenue
$437,421.00
N/A
Revenue This Year
N/A
$381.91
Revenue Next Year
N/A
N/A
P/E Ratio
$0.10
N/A
Revenue Growth
105.62
N/A
52 Week Low
$0.48
$0.71
52 Week High
$5.27
$3.31

Technical Indicators

Market Signals
Indicator
SOBR
RDHL
Relative Strength Index (RSI) 42.96 41.73
Support Level $0.51 $0.79
Resistance Level $1.03 $0.89
Average True Range (ATR) 0.07 0.05
MACD 0.02 0.01
Stochastic Oscillator 28.01 51.31

Price Performance

Historical Comparison
SOBR
RDHL

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: